Taisho Buys OTC Assets from Bristol-Myers
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 9 (Table of Contents)
Published: 24 Sep-2009
DOI: 10.3833/pdr.v2009.i9.1248 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In keeping with its aim of becoming a next generation leader in biopharma, Bristol-Myers Squibb has agreed to sell its over the counter (OTC) assets in Asia (excluding China and Japan) and its Indonesian unit to Taisho Pharmaceutical Co of Japan for US$310 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS